
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dendritic cells as shepherds of T cell immunity in cancer
Mikaël J. Pittet, Mauro Di Pilato, Christopher Garris, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2218-2230
Open Access | Times Cited: 92
Mikaël J. Pittet, Mauro Di Pilato, Christopher Garris, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2218-2230
Open Access | Times Cited: 92
Showing 1-25 of 92 citing articles:
The cancer-immunity cycle: Indication, genotype, and immunotype
Ira Mellman, Daniel S. Chen, Thomas Powles, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2188-2205
Open Access | Times Cited: 355
Ira Mellman, Daniel S. Chen, Thomas Powles, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2188-2205
Open Access | Times Cited: 355
CD8+ T cells in the cancer-immunity cycle
Josephine R. Giles, Anna-Maria Globig, Susan M. Kaech, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2231-2253
Open Access | Times Cited: 161
Josephine R. Giles, Anna-Maria Globig, Susan M. Kaech, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2231-2253
Open Access | Times Cited: 161
Dendritic cells as orchestrators of anticancer immunity and immunotherapy
Ignacio Heras‐Murillo, Irene Adán‐Barrientos, Miguel Á. Galán, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 257-277
Closed Access | Times Cited: 105
Ignacio Heras‐Murillo, Irene Adán‐Barrientos, Miguel Á. Galán, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 257-277
Closed Access | Times Cited: 105
Targeting innate immune pathways for cancer immunotherapy
Longyue L. Cao, Jonathan C. Kagan
Immunity (2023) Vol. 56, Iss. 10, pp. 2206-2217
Open Access | Times Cited: 78
Longyue L. Cao, Jonathan C. Kagan
Immunity (2023) Vol. 56, Iss. 10, pp. 2206-2217
Open Access | Times Cited: 78
Bispecific dendritic-T cell engager potentiates anti-tumor immunity
Y Itai, Oren Barboy, Ran Salomon, et al.
Cell (2024) Vol. 187, Iss. 2, pp. 375-389.e18
Open Access | Times Cited: 45
Y Itai, Oren Barboy, Ran Salomon, et al.
Cell (2024) Vol. 187, Iss. 2, pp. 375-389.e18
Open Access | Times Cited: 45
Cell shape sensing licenses dendritic cells for homeostatic migration to lymph nodes
Zahraa Alraies, Claudia A. Rivera, Maria–Graciela Delgado, et al.
Nature Immunology (2024) Vol. 25, Iss. 7, pp. 1193-1206
Open Access | Times Cited: 24
Zahraa Alraies, Claudia A. Rivera, Maria–Graciela Delgado, et al.
Nature Immunology (2024) Vol. 25, Iss. 7, pp. 1193-1206
Open Access | Times Cited: 24
Tumor-Microenvironment-Activatable Nanoparticle Mediating Immunogene Therapy and M2 Macrophage-Targeted Inhibitor for Synergistic Cancer Immunotherapy
Yuzhu Hu, Wen Nie, Liang Lyu, et al.
ACS Nano (2024) Vol. 18, Iss. 4, pp. 3295-3312
Closed Access | Times Cited: 17
Yuzhu Hu, Wen Nie, Liang Lyu, et al.
ACS Nano (2024) Vol. 18, Iss. 4, pp. 3295-3312
Closed Access | Times Cited: 17
Lactobacillus intestinalis facilitates tumor-derived CCL5 to recruit dendritic cell and suppress colorectal tumorigenesis
Yong Sun, Qiwen Wang, Yao Jiang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Yong Sun, Qiwen Wang, Yao Jiang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Dendritic cell maturation in cancer
Chang Moon, Meriem Belabed, Matthew D. Park, et al.
Nature reviews. Cancer (2025)
Closed Access | Times Cited: 2
Chang Moon, Meriem Belabed, Matthew D. Park, et al.
Nature reviews. Cancer (2025)
Closed Access | Times Cited: 2
Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies
Siwei Zheng, Wenwen Wang, Lesang Shen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Siwei Zheng, Wenwen Wang, Lesang Shen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Leveraging Senescent Cancer Cell Membrane to Potentiate Cancer Immunotherapy Through Biomimetic Nanovaccine
Chao Yang, Yinglu Chen, Jie Liu, et al.
Advanced Science (2024) Vol. 11, Iss. 30
Open Access | Times Cited: 10
Chao Yang, Yinglu Chen, Jie Liu, et al.
Advanced Science (2024) Vol. 11, Iss. 30
Open Access | Times Cited: 10
M7G-related tumor immunity: novel insights of RNA modification and potential therapeutic targets
Mengzhen Han, Qibo Huang, Xinxin Li, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 4, pp. 1238-1255
Open Access | Times Cited: 9
Mengzhen Han, Qibo Huang, Xinxin Li, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 4, pp. 1238-1255
Open Access | Times Cited: 9
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment
Douglas Hanahan, Olivier Michielin, Mikaël J. Pittet
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 9
Douglas Hanahan, Olivier Michielin, Mikaël J. Pittet
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 9
Next-generation combination approaches for immune checkpoint therapy
Sangeeta Goswami, Kristen E. Pauken, Linghua Wang, et al.
Nature Immunology (2024) Vol. 25, Iss. 12, pp. 2186-2199
Closed Access | Times Cited: 9
Sangeeta Goswami, Kristen E. Pauken, Linghua Wang, et al.
Nature Immunology (2024) Vol. 25, Iss. 12, pp. 2186-2199
Closed Access | Times Cited: 9
Architects of immunity: How dendritic cells shape CD8 + T cell fate in cancer
Vidit Bhandarkar, Teresa Dinter, Stefani Spranger
Science Immunology (2025) Vol. 10, Iss. 103
Closed Access | Times Cited: 1
Vidit Bhandarkar, Teresa Dinter, Stefani Spranger
Science Immunology (2025) Vol. 10, Iss. 103
Closed Access | Times Cited: 1
Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionality
Noor A. M. Bakker, Hannah Garner, Ewald van Dyk, et al.
npj Breast Cancer (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Noor A. M. Bakker, Hannah Garner, Ewald van Dyk, et al.
npj Breast Cancer (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Autologous Nanovaccine Induces Immunogenic Domino Effect to Prevent Postoperative Recurrence of Orthotopic Glioblastoma
Jinghong Yang, Ke Zhang, Guangliang Zhang, et al.
Advanced Functional Materials (2025)
Closed Access | Times Cited: 1
Jinghong Yang, Ke Zhang, Guangliang Zhang, et al.
Advanced Functional Materials (2025)
Closed Access | Times Cited: 1
Association between cancer-associated fibroblasts and prognosis of neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma: a bioinformatics analysis based on single-cell RNA sequencing
Zhao Huang, Zhuang‐Zhuang Cong, Jing Luo, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Zhao Huang, Zhuang‐Zhuang Cong, Jing Luo, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Combination of MHI148 Targeted Photodynamic Therapy and STING Activation Inhibits Tumor Metastasis and Recurrence
Huilin Yu, Qiaoqi Chen, Min Zheng, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 23, pp. 29672-29685
Closed Access | Times Cited: 7
Huilin Yu, Qiaoqi Chen, Min Zheng, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 23, pp. 29672-29685
Closed Access | Times Cited: 7
The impact of, and expectations for, lipid nanoparticle technology: From cellular targeting to organelle targeting
Yusuke Sato, Takashi Nakamura, Yuma Yamada, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 516-527
Closed Access | Times Cited: 6
Yusuke Sato, Takashi Nakamura, Yuma Yamada, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 516-527
Closed Access | Times Cited: 6
Stimulator of Interferon Genes-Activated Biomimetic Dendritic Cell Nanovaccine as a Chemotherapeutic Booster to Enhance Systemic Fibrosarcoma Treatment
Zhao Wang, Fenglin Miao, Lingwei Gu, et al.
ACS Nano (2024) Vol. 18, Iss. 35, pp. 24219-24235
Closed Access | Times Cited: 6
Zhao Wang, Fenglin Miao, Lingwei Gu, et al.
ACS Nano (2024) Vol. 18, Iss. 35, pp. 24219-24235
Closed Access | Times Cited: 6
NF-κB signaling pathway in tumor microenvironment
Yaning Cao, Yongqing Yi, Chongxu Han, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Yaning Cao, Yongqing Yi, Chongxu Han, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Neoantigen cancer vaccines: a new star on the horizon
Xiaoling Li, Jian You, Liping Hong, et al.
Cancer Biology and Medicine (2023), pp. 1-38
Open Access | Times Cited: 13
Xiaoling Li, Jian You, Liping Hong, et al.
Cancer Biology and Medicine (2023), pp. 1-38
Open Access | Times Cited: 13
Role of Exosomes in Cancer and Aptamer-Modified Exosomes as a Promising Platform for Cancer Targeted Therapy
Yating Wu, Yue Cao, Li Chen, et al.
Biological Procedures Online (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 5
Yating Wu, Yue Cao, Li Chen, et al.
Biological Procedures Online (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 5
Immunometabolism of ferroptosis in the tumor microenvironment
Gian Luca Lupica-Tondo, Emily N. Arner, Denis A. Mogilenko, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Gian Luca Lupica-Tondo, Emily N. Arner, Denis A. Mogilenko, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5